Friday, July 10, 2026

pharma · No medical condition. · Generalized Myasthenia Gravis

Anaxis Pharma

Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
642
Drugs
673
Patents
0
Clinical program

RES-6128-C1

Approved · small molecule · Severe vitamin D deficiency

RES-6128-C1 for Severe vitamin D deficiency is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Lacuna Pharma Pty Ltd projects Approved small molecule active

Internal code RES-6128-C1

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Lacuna Pharma Pty Ltd
Phase
Approved
Modality
small_molecule
Indication
Severe vitamin D deficiency
Status
active
Trials
1